Aspire Biopharma announces initial production order of 2M servings of BUZZ BOMB

Aspire Biopharma (ASBP) Holdings announced a strategic initiative to rapidly increase the production capacity of its BUZZ BOMB single dose caffeine pre-workout supplement through a new manufacturing relationship with SupraNaturals. As part of this agreement, Aspire Biopharma announced an initial production order of two million servings of BUZZ BOMB pre-workout supplement, marking a significant milestone in the Company’s expansion efforts.